PHMR

Tokyo Stock Market Sees Highest Level in 34 Years, Nikkei Average Jumps 900+ Yen

by
Tokyo Stock Market Sees Highest Level in 34 Years, Nikkei Average Jumps 900+ Yen

On the morning of February 13th, the Nikkei Stock Average on the Tokyo stock market rose by 901.47 yen from the previous business day to 37,798.89 yen, a significant increase for the third day in a row. The photo was taken in October 2020 at the Tokyo Stock Exchange in Tokyo (2024 Reuters/Kim Kyung-Hoon) TOKYO … Read more

A new report from UNICEF warns that people’s confidence in routine childhood vaccines has declined globally during the COVID-19 pandemic. In 52 out of 55 surveyed countries, public perception of vaccines for children declined between 2019 and 2021. Vaccine hesitancy poses a threat to children’s health as the next wave of deaths could be from preventable diseases like measles and diphtheria. Around 67 million children missed out on potentially lifesaving vaccines during the pandemic, but catching up efforts have stalled despite increasing outbreaks.

by

The COVID-19 pandemic has caused widespread disruptions to our daily lives, and it seems that even the most well-established medical practices are not immune to its effects. According to the United Nations Children’s Fund (UNICEF), the pandemic has sparked a growing distrust in childhood vaccines, which has the potential to have devastating consequences for public … Read more

Merck in Late-Stage Talks to Acquire Prometheus Biosciences Inc for Immune Disease Treatments

by

Merck & Co. is in the final stages of negotiations to acquire Prometheus Biosciences, Inc., a bioscience company that focuses on innovative therapies for immune and inflammatory disorders. According to sources familiar with the matter, the deal is expected to be completed soon, marking another major pharmaceutical acquisition in the biotech industry. This move is … Read more